Fourth dose of Pfizer vaccine may provide additional protection to elderly against severe disease: NEJM Written By Medical Dialogues Editorial Team8 April 2022 10:00 AM ISTIsrael: A new study conducted by Yinon M. Bar-On and the team found that after the fourth dose of BNT162b2 vaccination, rates of confirmed SARS-CoV-2...
BioNTech COVID vaccine causes deafness: WHO Isra Zaman5 April 2022 2:58 PM ISTAccording to a VigiBase report from WHO, instances of auditory loss also referred to as tinnitus was observed in people who were given Covid-19...
Nasal spray flu vaccine does not worsen asthma in children older than 4 years: study Written By Dr. Shravani Dali4 April 2022 9:00 AM ISTThe nasal spray flu vaccine does not exacerbate asthma in children older than 4 years, according to a recent study published in Pediatrics. Asthma...
COVID vaccine: Russia registers nasal version of Sputnik V Ruchika Sharma3 April 2022 11:30 AM ISTThe nasal vaccine will be efficient against the new Omicron coronavirus strain, Gintsburg said.
Pfizer COVID vaccine cut Omicron hospitalisations by 68 percent in kids aged 5-11 MD Bureau3 April 2022 10:30 AM ISTNew York: Vaccination of 5 to 11-year-olds reduced hospitalisations with Covid-19 by more than two thirds during the Omicron surge and also protected...
Biological E new recipient of mRNA technology through WHO technology transfer hub Ruchika Sharma2 April 2022 11:00 AM ISTWHO and partners will work with the Indian government and Bio E to develop a roadmap and put in place the necessary training and support so that the...
MoS Health Tells Rajya Sabha :Increase in Antibodies Post Covaxin Booster Dose Medical Dialogues Bureau31 March 2022 4:40 PM ISTNew Delhi: An ICMR study to examine the effect of Covaxin's booster dose has shown an increase in the levels of antibodies against SARS-CoV-2,...
FDA okays second booster of COVID-19 vaccine for select group Written By Dr. Kamal Kant Kohli30 March 2022 1:00 PM ISTA second booster dose of Pfizer or Moderna's COVID-19 vaccine has been authorized for adults ages 50 and up, as well as certain populations at risk...
Pfizer gets expanded USFDA emergency use nod for additional COVID Vaccine booster in adults aged 50 years and older Ruchika Sharma30 March 2022 12:25 PM ISTThe additional booster is to be administered at least four months after the first booster and is the same formulation and strength as prior...
Maternal tenofovir along with Vaccination may prevent Vertical Hepatitis B transmission Written By Medical Dialogues Editorial Team29 March 2022 9:00 AM ISTIn babies, a combination of hepatitis B vaccination and immunoglobulin is the cornerstone of vertical transmission prevention for women who are...
Serum Institute seeks DCGI emergency use nod for rBCG tuberculosis vaccine Ruchika Sharma28 March 2022 12:00 PM ISTNew Delhi: The Serum Institute has applied to the Drugs Controller General of India seeking emergency use authorisation for its recombinant BCG (rBCG)...
Sapigen Biologix, Technology Development Board collaborate for malaria, COVID nasal vaccine Ruchika Sharma28 March 2022 11:00 AM ISTNew Delhi: The Technology Development Board (TDB) of the Union Ministry of Science and Technology and Sapigen Biologix Private Limited, Hyderabad on...
